Kamal Ramzipoor

Biography

Ramzipoor is the president and chief executive officer of Amaranth Medical, Inc. He oversees all aspects of the company’s operations, including research and development, global manufacturing operations, regulatory, clinical and finance. Kamal has spent more than 28 years developing products and technologies for the medical device industry. Prior to co-founding Amaranth, he served as the director of the ischemic stroke franchise for the Neurovascular Division of Boston Scientific Corporation (BSC), where he was responsible for developing and managing a portfolio of “best in class” intravascular devices for the treatment of stroke. Before joining BSC, he was chief technology officer and vice president of research and development at Micrus Endovascular Corporation (acquired by Johnson & Johnson). Mr. Ramzipoor’s previous positions include senior director of research and development at Acuson Corporation (acquired by Siemens) and director of research and development at Progressive Angioplasty Systems.

Research Interest

research and development of Sciences